Rilpivirine, emtricitabine and tenofovir resistance in HIV-1 infected rilpivirine-naive patients failing antiretroviral therapy

S. Lambert-Niclot, C. Charpentier, A. Storto, D. Fofana, C. Soulie, S. Fourati, M. Wirden, L. Morand-Joubert, B. Masquelier, P. Flandre, V. Calvez, D. Descamps, and AG Marcelin. Journal of Antimicrobial Chemotherapy. 2014 Issue 69, accepted October 28, 2013, pages 1086-1089. This email address is being protected from spambots. You need JavaScript enabled to view it.

Citation: “... The definition of resistance in our study included 'resistance' and 'possible resistance'. Subtype determination was on the basis of the reverse transcriptase and protease coding regions (SmartGene, Switzerland; ...”